PureTech’s only internal drug program has slowed lung function decline in a phase 2 trial in idiopathic pulmonary fibrosis (IPF). The med, called deupirfenidone, is a deuterated form of Roche’s ...
Endeavor BioMedicines has linked its Hedgehog inhibitor to improved lung function in a phase 2a idiopathic pulmonary fibrosis (IPF) study, sending a sonic pulse through a sector currently dominated by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback